Member Info for mazik

It's big move and achievement for CTEA, having bought from 4p to 9p last year, now this end justify's its forward rerating..imo

Trippy agreed, future is bright with NHS exposure. See a multiple in front of us..

300k buyers are taking position, all postive after todays RNS "These patents are important to enhancing the value of the programme as part of our discussions with potential partners."

Hope it moves towards double figures 200k and 100k buyers are steaming in..

I am still using redesigned sidnofil by them and as limp as I can get... :-)

Bidnolid agree with u...its taking the pis* , hope they have learnt, how to draw a RNS..hence the delay...non-exec in history...lol. jokes apart update please...

Ahfam3 hah! hah!, Good luck I concur holding and loading for now until my target...

Afham great research thanks for sharing, looking for 50p at least in next three months...GLA

The granting of this patent in the US will provide a further layer of protection around SDC-1802 following the granting of patents protecting the molecule in the US and other major markets in recent years. These patents are important to enhancing the value of the programme as part of our discussions with potential partners

Double figures by midday, £3k topup calls for...next week range 10p to 15p

Excellent RNS, adding value for next three months "The granting of this patent in the US will provide a further layer of protection around SDC-1802 following the granting of patents protecting the molecule in the US and other major markets in recent years. These patents are important to enhancing the value of the programme as part of our discussions with potential partners"

Excellent news new range from today, glad we are holding. Company's SDC-1801 and SDC-1802 TYK2/JAK1 inhibitor drug development programmes as well as for working capital purposes. As noted in the Company's Trading Update of 25 May 2021, the Company is targeting the completion of preclinical studies for SDC-1801 in Q3 2021, subject to successful progress. Clinical trial plans, including priority autoimmune indications and potential Covid-19 application, will also be developed in parallel. Granting of patent in US is a big layer for Sar extensive value in front of us making of billion $ company imo

Advfn 100k buy at 16:41@ 9p

At close 9p today, well done who held..

Rentless buying, day traders back again , IMO... Double figures tomorrow... GL

Take over from big pharma....hello 50p.

Market Cap should be more like £200m not pidly £15m, chemist down the the road is worth more..:-)

Rentless buying to move up towards the next wave and range between 10 to 16 plus. Good Luck

Jas agree with u, patience will be rewarded.

Jas agree very positive trend , buyers moving in consistently by ignoring the shake